CHIRAL Ethical Review Board will also assess potential threats to the environment that may indirectly impact human health. The institutional research policy of CHIRAL stipulates that the organization will not engage in clinical trials involving new drugs, vaccines, or invasive medical devices, including human subjects. The IRB follows a standard guideline adapted from widely accepted ethical principles and regulations within the scientific community.